Advertisement
UK markets close in 4 hours 39 minutes
  • FTSE 100

    8,107.34
    +28.48 (+0.35%)
     
  • FTSE 250

    19,816.37
    +214.39 (+1.09%)
     
  • AIM

    755.77
    +2.65 (+0.35%)
     
  • GBP/EUR

    1.1658
    +0.0001 (+0.01%)
     
  • GBP/USD

    1.2511
    +0.0000 (+0.00%)
     
  • Bitcoin GBP

    51,313.23
    +436.18 (+0.86%)
     
  • CMC Crypto 200

    1,388.20
    -8.34 (-0.60%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    84.08
    +0.51 (+0.61%)
     
  • GOLD FUTURES

    2,359.20
    +16.70 (+0.71%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,044.69
    +127.41 (+0.71%)
     
  • CAC 40

    8,030.88
    +14.23 (+0.18%)
     

Analyst Recommendations for Merck & Co. in November 2017

Wall Street analysts estimate Merck & Co.’s (MRK) top line to rise 1.1% to ~$40.2 billion in 2017. EPS (earnings per share) is expected to be $3.94 for 2017.